Browse Items (1 total)

BACKGROUND: Mineralocorticoid receptor antagonists (MRAs) improve survival among patients with heart failure with reduced ejection fraction (HFrEF); however, studies have identified low utilization rates. No study has evaluated the prevalence and…
Output Formats

atom, dcmes-xml, json, omeka-xml, rss2